Ziauddin university
Karachi, Sindh, Pakistan
NCT Number: NCT07097441
The goal of this clinical trial is to to observe the haemodynamic parameters including Heart Rate Blood pressure Respiratory rate and Oxygen Saturation with or without giving reversal agent on extubation in patients receiving atracurium on induction , it will also observe post operative residual paralysis respiratory depression and airway reflexes in the post anaesthesia care unit Researchers will compare neostigmine which is the reversal agent and the placebo drug by giving it at the end on surgery before extubation to observe haemodynamic parameters The main questions it aims to answer are Will participants have a stable haemodymaics if no reversal ( neostigmine ) is used during extubation Will it provide a safe extubation and no complications post operatively Participants will be given Either neostigmine or placebo drug at the end of surgery before extubation Will be obseved and monitored for two hours postoperatively in the post anaesthesia care unit Will be monitored for post operative complications like respiratory depression or residual paralysis
.
Looking for future studies?
Notify Me16 year–70 year
All sexes
Interventional
Phase 1 / Phase 2
Karachi, Sindh, Pakistan
Objective : To observe the haemodynamic parameters including Heart Rate Blood pressure Respiratory rate and Oxygen Saturation with or without giving reversal agent on extubation in patients receiving atracurium on induction , and secondary objective was to observe post operative residual paralysis respiratory depression and cough and gag reflex Study design : Controlled , randomised , and triple Blind trial . Place and duration of study: Dr Ziauddin Hospital Clifton Karachi , from March to June 2025.
Methodology : This was a triple blind study . A total of 100 patients were randomly assigned by the CTU to two groups , the placebo group ( Group A ) and the neoglycopyrolate group (Group B) based on computer generated allocation. At the end of the surgery, patients in Group A were administered IV normal saline and Group B were administered neoglycopyrolate 50 mcg/kg . The primary outcome was to observe heart rate , blood pressure, oxygen saturation and respiratory rate after giving the drug , before extubation , at extubation and at 1mins, 5mins, 10mins, 20mins, and 2h thereafter, while the secondary outcome was to observe post operative airway reflexes and residual paralysis in the post anaesthesia care unit
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At the end of surgery patients will be given placebo ( normal saline ) instead of neostigmine ( reversal agent of atracurium ) , to observe Heart rate, blood pressure , respiratory rate and oxygen saturation on extubation and post operative airway reflexes and residual paralysis
Other names: Group A
At the end of surgery patients will be given neostigmine ( reversal agenr ) , to observe Heart rate, blood pressure , respiratory rate and oxygen saturation on extubation and post operative airway reflexes and residual paralysis
Other names: Group B
Time frame: From the time of extubation till discharge from post anaesthesia care unit
To observe Heart rate, via pulse oximeter and ECG
Time frame: From the time of extubation till discharge from post anaesthesia care unit
to observe Blood Pressure via Sphygmomanometer
Time frame: From the time of extubation till discharge from post anaesthesia care unit
to observe respiratory rate via capnometer
Time frame: From the time of extubation till discharge from post anaesthesia care unit
to observe oxygen saturation via pulse oximeter
Time frame: From the time of extubation till discharge from post anaesthesia care unit
to observe cough and gag reflex via Binary scale e.g Yes/No
Time frame: From the time of extubation till discharge from post anaesthesia care unit
to observe head lift for more than 5 secs and firm hand grip via Bonary scale e.g Yes/No
Ziauddin University
Other
Effect of the Use of Atracurium With or Without Reversal Agent on Haemodynamic Parameters During Extubation: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258628
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07385040
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Karachi, Sindh, Pakistan
View Trial DetailsNCT00644644
Arrhythmias, Cardiac, Bradycardia
Nashville, Tennessee, United States
View Trial DetailsNCT02608775
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Jette, Belgium
View Trial Details